Mitomycin C is a clinically useful antineoplastic antibiotic compound1)2),but its use is limited by side effects, such as severe bone marrowsuppression or gastrointestinal damage. In the hope of obtaining compounds with improved therapeutic properties, a number of derivatives have been prepared. Preparation of new mitomycin analogues have involved substituents on the aziridine ring3'40, and carbamoyloxymethyl side chain5), and replace-1815 ment of 7-substituent in the quinone ring with other functional groups, especially substituted amines6~10). But little is known concerning derivatives of 6-substituent of mitomycins1 1'12*.
In this communication we report the synthesis of 6-demethyl-6-formylmitomycin C (1) which could be a good starting material for various kinds of 6-position derivatives, and also report the cytotoxic activity of 1 and its several derivatives. After testing many oxidizing agents, activated manganese(IV) oxide was found to be the best for oxidation of the 6-methyl group of mitomycin C. Compound1 was prepared from mitomycin C by oxidation with activated manganese(IV) oxide as follows. To a solution of mitomycinC in ethyl acetate, an excess of activated manganese(IV) oxide was added. After stirring the reaction mixture for 2 hours at roomtemperature, 1 was separated as an almost single compound fromthe reaction mixture by washing manganese(IV) oxide with ethyl acetate several times. Thus 1 was easily prepared by a one step reaction in 77% yield (Table 1) . Mitomycin A, however, was not oxidized under the same condition as that of mitomycin C. The 7-amino group of mitomycinC appears to enable the conversion of the neighboring 6-methyl group to the formyl group.
The structure of 1 was elucidated by detailed analyses of the :H NMRand 13C NMR(400MHz, CDC13) spectral data ( Table 2 ). The presence of the formyl group at 3 10.04ppm and a disappearance of the C-6 methyl group whose signal was at 6 1.90ppm in case of mitomycin C proved that the 6-methyl group was converted into the 6-formyl group. All of the other signals corresponded to the rest of the structure of 6-demethyl-6-formylmitomycinC. For further confirmation of the structure of 1, several Schiffbase (2, 3, 4 and 5) of 1 were prepared in the usual method. The structures of these compounds (2, 3, 4 and 5) were established by comparing their *H NMRspectral data with that of 1. One of the major differences is that compounds 2, 3, 4 and 5 lack a formyl proton and a new peak due to the imino group (-N=CH-) appeared at 6 8. 24, 8.82, 8.58 and 9.38ppm corresponding to compounds 2, 3, 4 and 5, respectively.
The cytotoxicity and antimicrobial activity of 1 and its derivatives (2, 3, 4 and 5) against B-16 a B-16 melanoma cell was exposed to the compounds for 3 days, and growth rates were examined as reported previously1 3). b Antimicrobial activities of these compounds at a concentration of 25/xg/ml were examined on agar plate by paper disc method (6mm)13). melanomacells and two strains of bacteria are shown in Table 3 . Cytotoxicity of these compounds generally correlates to antibacterial activity. Compound 5 was relatively potent amongthe compounds tested. While these compoundshad less activity than mitomycin C, compound1 is a promising starting material for further derivatives.
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